-
1.
公开(公告)号:US08202971B2
公开(公告)日:2012-06-19
申请号:US12499767
申请日:2009-07-08
申请人: Xiguang Chen , Jing Li , Xiaojie Cheng , Tao Jiang
发明人: Xiguang Chen , Jing Li , Xiaojie Cheng , Tao Jiang
IPC分类号: C08B37/08
CPC分类号: C08B37/003
摘要: A process for preparing compounds of chitosan saccharified with aminosugar, adopts chitosan derivatives, aminosugar derivatives and anhydride derivatives as raw materials to synthesize target products. The process comprises: covalently bonding an anhydride derivative as a bonding arm to an aminosugar derivative, so as to form a monosaccharide derivative having an end group of carboxyl; and then covalently bonding the monosaccharide derivative having an end group of carboxyl to a primary amino group of a chitosan derivative via the carboxyl, so as to form a compound of chitosan saccharified with aminosugar.
摘要翻译: 用氨基糖糖化糖壳化合物的方法,采用壳聚糖衍生物,氨基糖衍生物和酸酐衍生物为原料合成目标产物。 该方法包括:将作为结合臂的酸酐衍生物与氨基糖衍生物共价键合,形成具有羧基端基的单糖衍生物; 然后通过羧基将具有羧基末端基团的单糖衍生物共价键合到壳聚糖衍生物的伯氨基上,以形成用氨基糖糖化的壳聚糖化合物。
-
2.
公开(公告)号:US20100152430A1
公开(公告)日:2010-06-17
申请号:US12499767
申请日:2009-07-08
申请人: Xiguang Chen , Jing Li , Xiaojie Cheng , Tao Jiang
发明人: Xiguang Chen , Jing Li , Xiaojie Cheng , Tao Jiang
CPC分类号: C08B37/003
摘要: A process for preparing compounds of chitosan saccharified with aminosugar, adopts chitosan derivatives, aminosugar derivatives and anhydride derivatives as raw materials to synthesize target products. The process comprises: covalently bonding an anhydride derivative as a bonding arm to an aminosugar derivative, so as to form a monosaccharide derivative having an end group of carboxyl; and then covalently bonding the monosaccharide derivative having an end group of carboxyl to a primary amino group of a chitosan derivative via the carboxyl, so as to form a compound of chitosan saccharified with aminosugar.
摘要翻译: 用氨基糖糖化糖壳化合物的方法,采用壳聚糖衍生物,氨基糖衍生物和酸酐衍生物为原料合成目标产物。 该方法包括:将作为结合臂的酸酐衍生物与氨基糖衍生物共价键合,形成具有羧基端基的单糖衍生物; 然后通过羧基将具有羧基末端基团的单糖衍生物共价键合到壳聚糖衍生物的伯氨基上,以形成用氨基糖糖化的壳聚糖化合物。
-
-
公开(公告)号:US08592432B2
公开(公告)日:2013-11-26
申请号:US12936199
申请日:2009-04-03
申请人: Bei Chen , Tao Jiang , Thomas H. Marsilje , Pierre-Yves Michellys , Truc Ngoc Nguyen , Wei Pei , Baogen Wu , Zhaobo Gao , Yonghui Ge , Chen Huang , Yuncheng Li , Xuefeng Zhu
发明人: Bei Chen , Tao Jiang , Thomas H. Marsilje , Pierre-Yves Michellys , Truc Ngoc Nguyen , Wei Pei , Baogen Wu , Zhaobo Gao , Yonghui Ge , Chen Huang , Yuncheng Li , Xuefeng Zhu
IPC分类号: A61K31/506 , A61K31/5377 , C07D239/42 , C07D239/30 , C07D295/108 , C07D487/04 , A61P35/00 , A61P35/02 , A61P35/04
CPC分类号: C07D239/48 , C07D403/12 , C07D403/14 , C07D487/04
摘要: The invention provides novel pyrimidine derivatives and pharmaceutical compositions thereof, and methods for using such compounds. For example, the pyrimidine derivatives of the invention may be used to treat, ameliorate or prevent a condition which responds to inhibition of anaplastic lymphoma kinase (ALK) activity, c-ros oncogene (ROS), insulin-like growth factor (IGF-1R), and/or insulin receptor (InsR) or a combination thereof.
摘要翻译: 本发明提供新颖的嘧啶衍生物及其药物组合物,以及使用这些化合物的方法。 例如,本发明的嘧啶衍生物可用于治疗,改善或预防对间变性淋巴瘤激酶(ALK)活性,c-ros致癌基因(ROS),胰岛素样生长因子(IGF-1R )和/或胰岛素受体(InsR)或其组合。
-
5.
公开(公告)号:US08524904B2
公开(公告)日:2013-09-03
申请号:US12630192
申请日:2009-12-03
申请人: Christopher W. Grote , Peter X. Wang , Tao Jiang , Gary L. Cantrell , Frank W. Moser , Catherine E. Thomasson
发明人: Christopher W. Grote , Peter X. Wang , Tao Jiang , Gary L. Cantrell , Frank W. Moser , Catherine E. Thomasson
IPC分类号: C07D489/08 , C07D489/02
CPC分类号: C07D489/02 , Y02P20/55
摘要: The present invention is directed to the preparation of 6-hydroxy morphinans having formula (II) or N-alkylated 6-hydroxy morphinans having formula (III).
摘要翻译: 本发明涉及具有式(II)的6-羟基吗啡烷或具有式(III)的N-烷基化的6-羟基吗啡喃的制备。
-
公开(公告)号:US20130131699A1
公开(公告)日:2013-05-23
申请号:US13679041
申请日:2012-11-16
申请人: Tao Jiang , Jian Q. Yao , Hali Wang , Timothy A. Hoeman , Ray Zubok , John Chernosky , Keith A. Roby
发明人: Tao Jiang , Jian Q. Yao , Hali Wang , Timothy A. Hoeman , Ray Zubok , John Chernosky , Keith A. Roby
IPC分类号: A61B17/68
CPC分类号: A61F2/0811 , A61B17/68 , A61F2002/0858 , A61F2002/0888 , A61F2250/0021 , A61F2250/0023 , A61F2250/0026 , A61L27/04 , A61L27/56
摘要: The present disclosure relates, in some aspects, to orthopaedic implants for securing soft tissue to bone and methods for using the same. One particular implant comprises a first exposed porous surface region, having pores for promoting bone ingrowth, and a second exposed porous surface, having pores for promoting soft tissue ingrowth. At least some of the pores of the first exposed porous surface region may be seeded with osteocytic factors and at least some of the pores of the second exposed porous surface region may be seeded with fibrocytic factors. Such orthopaedic implants can advantageously facilitate regeneration of the soft tissue to bone interface.
-
公开(公告)号:US20130005748A1
公开(公告)日:2013-01-03
申请号:US13610422
申请日:2012-09-11
申请人: Pierre-Yves Michellys , Wei Pei , Thomas H. Marsilje , Wenshuo Lu , Bei Chen , Tetsuo Uno , Yunho Jin , Tao Jiang
发明人: Pierre-Yves Michellys , Wei Pei , Thomas H. Marsilje , Wenshuo Lu , Bei Chen , Tetsuo Uno , Yunho Jin , Tao Jiang
IPC分类号: A61K31/519 , A61P31/00 , A61P35/00 , A61P37/06 , A61K31/52 , A61K31/517
CPC分类号: A61K31/506 , A61K31/5377 , A61K45/06 , C07D213/74 , C07D239/48 , C07D239/95 , C07D401/12 , C07D401/14 , C07D403/12 , C07D403/14 , C07D405/14 , C07D413/12 , C07D417/12 , C07D451/02 , C07D453/02 , C07D471/04 , C07D473/16 , C07D487/04 , C07D487/08
摘要: The invention provides novel pyrimidine and pyridine derivatives and pharmaceutical compositions thereof, and methods for using such compounds. For example, the pyrimidine and pyridine derivatives of the invention may be used to treat, ameliorate or prevent a condition which responds to inhibition of anaplastic lymphoma kinase (ALK) activity, focal adhesion kinase (FAK), zeta-chain-associated protein kinase 70 (ZAP-70), insulin-like growth factor (IGF-1R), or a combination thereof.
-
8.
公开(公告)号:US08252928B2
公开(公告)日:2012-08-28
申请号:US12558646
申请日:2009-09-14
申请人: Peter X. Wang , Tao Jiang , David W. Berberich
发明人: Peter X. Wang , Tao Jiang , David W. Berberich
IPC分类号: C07D489/02 , C07D489/08
CPC分类号: C07D489/02 , C07D489/00
摘要: The present invention provides processes for the synthesis of five and six membered rings. In particular, the present invention provides processes for the synthesis of five and six membered rings in alkaloids.
摘要翻译: 本发明提供合成五元和六元环的方法。 特别地,本发明提供了合成生物碱中五元和六元环的方法。
-
公开(公告)号:US20120134931A1
公开(公告)日:2012-05-31
申请号:US13384591
申请日:2010-07-15
申请人: Roger Tsien , Tood Aguilera , Emilia Olson , Tao Jiang , Quyen Nguyen
发明人: Roger Tsien , Tood Aguilera , Emilia Olson , Tao Jiang , Quyen Nguyen
CPC分类号: A61K47/64 , A61K47/595 , A61K47/60 , A61K47/62 , A61K47/6911 , A61K49/0032 , A61K49/0056 , C07K7/06
摘要: Disclosed herein, in certain embodiments, is a selective transport molecule with increased in vivo circulation. In some embodiments, a selective transport molecule disclosed herein has the formula (A-X-B-C)-M, wherein C is a cargo moiety; A is a peptide with a sequence comprising 5 to 9 consecutive acidic amino acids, wherein the amino acids are selected from: aspartates and glutamates; B is a peptide with a sequence comprising 5 to 20 consecutive basic amino acids; X is a linker; and M is a macromolecular carrier.
摘要翻译: 在某些实施方案中,本文公开了具有增加的体内循环的选择性转运分子。 在一些实施方案中,本文公开的选择性转运分子具有式(A-X-B-C)-M,其中C是货物部分; A是具有包含5至9个连续酸性氨基酸的序列的肽,其中所述氨基酸选自:天冬氨酸和谷氨酸; B是具有包含5至20个连续碱性氨基酸的序列的肽; X是一个连接子; M是大分子载体。
-
公开(公告)号:US08101757B2
公开(公告)日:2012-01-24
申请号:US12316887
申请日:2008-12-17
申请人: Peter X. Wang , Tao Jiang , Gary L. Cantrell , David W. Berberich , Jian Bao , Bobby N. Trawick
发明人: Peter X. Wang , Tao Jiang , Gary L. Cantrell , David W. Berberich , Jian Bao , Bobby N. Trawick
IPC分类号: C07D489/02 , C07D489/08
CPC分类号: C07D489/08
摘要: The invention provides a process for the conversion of opioid derivatives into normorphinan compounds useful for making “nal” compound analgesics and antagonists. In particular, the process may be used for the production of pure normorphinan salts from crude opioid substrates.
摘要翻译: 本发明提供了一种将阿片样物质衍生物转化成可用于制备“nal”复合镇痛药和拮抗剂的正大脑啡肽化合物的方法。 特别地,该方法可用于从粗制阿片样物质底物生产纯的正大脑啡肽。
-
-
-
-
-
-
-
-
-